US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% SNDK $1,704.16 ▼-0.92%
FinancialContent

Seer, Inc. - Class A Common Stock (NQ:SEER)

2.330 +0.080 (+3.56%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seer, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Recap: Seer Q4 Earnings ↗
 
Via Benzinga
News headline image
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data 
From Seer, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
News headline image
Zoom Video And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Why Shares of Seer Are Slumping Wednesday ↗
The company reported a net loss but improved revenue in the second quarter. 
Via The Motley Fool
News headline image
Seer: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
Seer technology receives recognition for excellence in the field of proteomics 
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Reports Third Quarter 2023 Financial Results
Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence 
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services 
From Seer, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
From Seer, Inc.
Via GlobeNewswire
News headline image
7 Contrarian Stocks to Buy for the High-Stakes Gambler ↗
With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. 
Via InvestorPlace
News headline image
Seer to Participate in Upcoming September Investor Conferences
From Seer, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Seer Reports Second Quarter 2023 Financial Results
Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies 
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Seer, Inc.
Via GlobeNewswire
News headline image
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC. 
Via Benzinga
News headline image
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center
Expanded collaboration with Thermo Fisher Scientific combines the new Seer Proteograph™ XT Assay Kit with the new Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer to empower the scientific... 
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies
Seer’s Proteograph XT pushes the boundaries of biological discovery by enabling rapid proteomics across a range of sample types and species with unprecedented resolution and scale 
From Seer, Inc.
Via GlobeNewswire
News headline image
Seer Reports First Quarter 2023 Financial Results
From Seer, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >